ライフサイエンスコーパス: yellow fever virus

1 us, Murray Valley virus, Powassan virus, and yellow fever virus).

2 es or West Nile virus, or vaccinated against yellow fever virus.

3 iated mosquito-borne flaviviruses, including yellow fever virus.

4 rica to understand and predict the spread of yellow fever virus.

5 s, including pathogens such as influenza and yellow fever virus.

6 EN) 4 virus was chimerized with the WT Asibi yellow fever virus.

7 lustered substitutions in the NS1 protein of yellow fever virus.

8 ot neutralize or immune-precipitate mumps or yellow fever viruses.

9 diseases that include West Nile, dengue and yellow fever viruses.

10 of other flaviviruses, including dengue and yellow fever viruses.

11 nction of NS4B is conserved in West Nile and yellow fever viruses.

12 wing ex vivo exposure to the live attenuated yellow fever virus 17D strain vaccine, a virus that we s

13 s of the flavivirus dengue virus (DV) and by yellow fever virus 17D were cholesterol independent, and

14 ift Valley fever virus, West Nile virus, and yellow fever virus), 8 bacteria (Bartonella spp., Brucel

15 The capsid proteins of two flaviviruses, yellow fever virus and dengue virus, were expressed in E

16 ext of published studies of vaccines against yellow fever virus and influenza virus.

17 sis of CD8(+) T cells responding to the live yellow fever virus and smallpox vaccines--two highly suc

18 include the 2 flaviviruses dengue virus and yellow fever virus and the alphavirus chikungunya virus,

19 In contrast, yellow fever virus and West Nile virus were partially an

20 ding vesicular stomatitis virus, poliovirus, yellow fever virus, and herpes simplex virus type 1, rep

21 Arboviruses like dengue virus, yellow fever virus, and West Nile virus are enveloped pa

22 ncluding all four serotypes of dengue virus, yellow fever virus, and West Nile virus.

23 vectors of African malaria, dengue fever and yellow fever viruses, and lymphatic filariasis, respecti

24 nd other flaviviruses, such as West Nile and yellow fever viruses, contain a 5' m7GpppN-capped positi

25 curred in NS2B-NS3 recombinant proteins from yellow fever virus, dengue virus types 2 and 4, and Japa

26 ing three members of the family Flaviviridae(yellow fever virus, dengue virus, and bovine viral diarr

27 Flaviviruses, such as Zika virus, yellow fever virus, dengue virus, and West Nile virus (W

28 cutive plaque purifications of four chimeric yellow fever virus-dengue virus (ChimeriVax-DEN) vaccine

29 f 18 nucleotides (residues 146 to 163 of the yellow fever virus genome, which encode amino acids 9 to

30 ucleotide sequence found in the 5' region of yellow fever virus genomic RNA that is required for RNA

31 Yellow fever virus has four basic residues (Arg-Lys-Arg-

32 However, dengue, chikungunya, and yellow fever viruses have repeatedly initiated urban tra

33 eplication of infectious West Nile virus and yellow fever virus in cell culture with low toxicity.

34 The data indicate that persistence of yellow fever virus in NB41A3 cells is associated with a

35 Two forms of NS2A are found in yellow fever virus-infected cells.

36 ogistic model to infer the district-specific yellow fever virus infection risk during the course of t

37 Vaccine strains of yellow fever virus, isolated from the plasma of two pati

38 ephalitis virus, norovirus, metapneumovirus, yellow fever virus, Japanese encephalitis virus, parainf

39 that the E protein is a critical factor for yellow fever virus neuropathogenesis in the SCID mouse m

40 Dengue, West Nile, or yellow fever virus NS1 directly associated with C4b bind

41 directed against a conserved immunodominant yellow fever virus NS3 epitope.

42 Structures of prM-containing dengue and yellow fever virus particles were determined to 16 and 2

43 The past evolution of the dengue and yellow fever viruses provides clues about the influence

44 In contrast, an unrelated flavivirus, yellow fever virus, replicated equally well in uninfecte

45 protein) is essential for replication of the yellow fever virus replicon and that a slightly longer s

46 30451, specifically blocked translation of a yellow fever virus replicon but not a Sindbis virus repl

47 ed nucleotide and that the error rate of the yellow fever virus RNA polymerase employed by the chimer

48 ly proposed to be involved in cyclization of yellow fever virus RNA.

49 d mosquito-borne flaviviruses, which include yellow fever virus, Sepik virus, Saboya virus, and other

50 wide range of viruses, including DENV, WNV, yellow fever virus, Sindbis virus, Venezuelan equine enc

51 o many flavivirus types including Dengue and yellow fever viruses, the nonstructural NS3 multifunctio

52 trative division across countries at risk of yellow fever virus transmission from 1970 to 2016.

53 till require vaccination in areas at risk of yellow fever virus transmission to achieve the 80% popul

54 This live attenuated yellow fever virus vaccine yields sterile, long-term imm

55 The early spread of yellow fever virus was characterised by fast exponential

56 Vaccine-related variants of yellow fever virus were found in plasma and cerebrospina

57 ax-II), rotavirus (Rotateq and Rotarix), and yellow fever virus were negative for XMRV and highly rel

58 animal viruses, including hepatitis C virus, yellow fever virus, West Nile virus, chikungunya virus,

59 Binding of yellow fever virus wild-type strains Asibi and French vi

60 The ChimeriVax technology utilizes yellow fever virus (YF) 17D vaccine strain capsid and no

61 ysis of the nonstructural protein 1 (NS1) of yellow fever virus (YF) has implicated it in viral RNA r

62 Nonstructural protein 1 (NS1) of yellow fever virus (YF) is a glycoprotein localized to e

63 y, of bovine viral diarrhea virus (BVDV) and yellow fever virus (YF), members of the other two establ

64 e a high mosquito infectivity phenotype, the yellow fever virus (YFV) 17D backbone of the ChimeriVax-

65 A neuroadapted strain of yellow fever virus (YFV) 17D derived from a multiply mou

66 The live attenuated yellow fever virus (YFV) 17D vaccine provides a good mod

67 phosphorylation sites of the NS5 proteins of yellow fever virus (YFV) and dengue virus (DENV), two fl

68 Previous studies of yellow fever virus (YFV) and dengue virus have found tha

69 tricts two medically important flaviviruses, yellow fever virus (YFV) and dengue virus serotype 2 (DE

70 Arboviruses such as yellow fever virus (YFV) are transmitted between arthrop

71 Yellow fever virus (YFV) can induce acute, life-threaten

72 Here we show that yellow fever virus (YFV) inhibits IFN-I signaling throug

73 Yellow fever virus (YFV) is the prototype member of the

74 sequencing is presented using as a model the yellow fever virus (YFV) live vaccine strain 17D-204 and

75 It was previously reported that mutations in yellow fever virus (YFV) nonstructural protein NS2A bloc

76 gue virus (DENV), West Nile virus (WNV), and yellow fever virus (YFV) NS1 attenuate classical and lec

77 verexpressed DNAJC14 is targeted to sites of yellow fever virus (YFV) replication complex (RC) format

78 Here we describe a two-component genome yellow fever virus (YFV) replication system in which eac

79 s-packaging system that involved packaging a yellow fever virus (YFV) replicon into pseudo-infectious

80 A molecular clone of yellow fever virus (YFV) strain 17D was used to identify

81 safety and immunogenicity of live attenuated yellow fever virus (YFV) vaccination of nonatopic subjec

82 In this study, we used the live attenuated yellow fever virus (YFV) vaccine 17D as a human in vivo

83 Here we address this issue using the live yellow fever virus (YFV) vaccine, which induces long-ter

84 Yellow fever virus (YFV), a member of the Flavivirus gen

85 ose of tick-borne encephalitis virus (TBEV), yellow fever virus (YFV), and Japanese encephalitis viru

86 th threats, including dengue viruses (DENV), yellow fever virus (YFV), and Zika virus (ZIKV).

87 of many important human pathogens including yellow fever virus (YFV), dengue virus (DENV), and Zika

88 that TRIM56 poses a barrier to infections by yellow fever virus (YFV), dengue virus serotype 2 (DENV2

89 involves the gene-specific amplification of yellow fever virus (YFV), Japanese encephalitis virus (J

90 Using yellow fever virus (YFV), we demonstrate that DNAJC14 re

91 + T cells specific for a single epitope from Yellow Fever Virus (YFV), we show that the recently desc

92 Mosquito-borne flaviviruses, including yellow fever virus (YFV), Zika virus (ZIKV), and West Ni

93 ine (BDAA) compound, which potently inhibits yellow fever virus (YFV).

94 Two yellow fever virus (YFV)/dengue virus chimeras which enc

95 A yellow fever virus (YFV)/Japanese encephalitis virus (JE

96 e insights into how a prototypic flavivirus, yellow fever virus (YFV-17D), differentially interacts w

97 ed mice before and after vaccination against yellow fever virus (YFV-17D).

98 DV, hepatitis C virus, West Nile virus, and yellow fever virus (YFV; vaccine strain 17D) were expres